Development and validation of a three-long noncoding RNA signature for predicting prognosis of patients with gastric cancer

doi:10.3748/wjg.v26.i44.6929

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 44

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6995)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

307

WORD

194

HTML

2137

Figures (1-5)

300

Tables (1-3)

351

Sum=3289

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

323

Download

787

Sum=1110

Publishing Process of This Article

Item

Count

Browse

739

Download

1857

Sum=2596

Nov 28, 2020 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Nov 28, 2020; 26(44): 6929-6944
Published online Nov 28, 2020. doi: 10.3748/wjg.v26.i44.6929

Table 2 Multivariate analysis of significant prognostic factors for survival in gastric cancer patients

Variable	Disease-free survival			Overall survival
	P value	HR	95%CI	P value	HR	95%CI
Bormann type	0.20	1.26	0.90-1.77	0.13	1.29	0.93-1.91
Tumor size	0.41	0.86	0.59-1.24	0.40	0.85	0.59-1.24
Vessel invasion	0.06	0.70	0.48-1.01	0.16	0.76	0.53-1.11
Perineural invasion	0.24	0.80	0.56-1.16	0.09	0.73	0.50-1.05
TNM stage	0.00	106.50	30.76-368.77	0.00	94.08	30.14-293.65
Model	0.04	2.27	1.46-3.99	0.03	2.64	1.74-4.27

HR: Hazard ratio; CI: Confidence interval; TNM: Tumor-node-metastasis.

Citation: Zhang J, Piao HY, Wang Y, Lou MY, Guo S, Zhao Y. Development and validation of a three-long noncoding RNA signature for predicting prognosis of patients with gastric cancer. World J Gastroenterol 2020; 26(44): 6929-6944
URL: https://www.wjgnet.com/1007-9327/full/v26/i44/6929.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i44.6929